Evidence map›Paper›PMID 26924992›Full record

ArticleFrontiers in psychiatry2016

Development of the Positive Emotions Program for Schizophrenia: An Intervention to Improve Pleasure and Motivation in Schizophrenia.

Alexandra Nguyen, Laurent Frobert, Iannis McCluskey, Philippe Golay, Charles Bonsack, Jérôme Favrod

Registry-linked trialOpen access · goldAbstract read
In one paragraph

Article in Frontiers in psychiatry, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT02593058 (Positive Emotions Program for Schizophrenia), which is not on this map. Cited by 18 papers.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed
4.2field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT02593058 nacompletednot on this map

Positive Emotions Program for Schizophrenia (PEPS): A Randomized Controlled Study on Improving Pleasure and Motivation in Schizophrenia

TypeinterventionalSponsorInstitut et Haute Ecole de la Santé la SourceRan2016 to 2018Enrolled80ConditionsSchizophrenia, Schizoaffective DisorderArmsPositive Emotions Program for Schizophrenia, Treatment As Usual
3 · Its place in the literature

Who cites it

18 citing papers in PubMed, 54 citations in OpenAlex.

  1. Trial
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Review
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Alexandra NguyenSchool of Nursing Science La Source, University of Applied Sciences and Arts of Western Switzerland , Lausanne , Switzerland.
Laurent FrobertSchool of Nursing Science La Source, University of Applied Sciences and Arts of Western Switzerland , Lausanne , Switzerland.
Iannis McCluskeySchool of Nursing Science La Source, University of Applied Sciences and Arts of Western Switzerland, Lausanne, Switzerland; Social Psychiatry Section, Community Psychiatry Service, Department of Psychiatry, University Hospital Center, Lausanne, Switzerland.
Philippe GolaySocial Psychiatry Section, Community Psychiatry Service, Department of Psychiatry, University Hospital Center , Lausanne , Switzerland.
Charles BonsackSocial Psychiatry Section, Community Psychiatry Service, Department of Psychiatry, University Hospital Center , Lausanne , Switzerland.
Jérôme FavrodSchool of Nursing Science La Source, University of Applied Sciences and Arts of Western Switzerland, Lausanne, Switzerland; Social Psychiatry Section, Community Psychiatry Service, Department of Psychiatry, University Hospital Center, Lausanne, Switzerland.
HES-SO University of Applied Sciences and Arts Western Switzerland · CH

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectivesThe efficacy of drug-based treatments and psychological interventions on the primary negative symptoms of schizophrenia remains limited. Recent literature has distinguished negative symptoms associated with a diminished capacity to experience, from those associated with a limited capacity for expression. The positive emotions program for schizophrenia (PEPS) is a new method that specifically aims to reduce the syndrome of a diminished capacity to experience.

methodsThe intervention's vital ingredients were identified through a literature review of emotion in schizophrenia and positive psychology. The program has been beta-tested on various groups of health-care professionals.

resultsA detailed description of the final version of PEPS is presented here. The French version of the program is freely downloadable.

conclusionPEPS is a specific, short, easy to use, group-based intervention to improve pleasure, and motivation in schizophrenia. It was built considering a recovery-oriented approach to schizophrenia.

Indexed as

anhedoniaapathymotivationpleasurepsychosocial interventionsschizophrenia

Identifiers

PMID26924992
PMCPMC4756115
OpenAlexW2281691319

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.